tradmap

CGTX Earnings COGNITION THERAPEUTICS INC

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$24 -$12 $0 2020 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$34M -$17M $0 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-181% -85% 11% 0% 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$10M -$5M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income
Return on equity (quarterly)
-96% -48% 0% Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
ROE

Reported EPS history

1–24 of 24
Q2 20262026-06-30-0.092026-08-0710-Q
Q1 20262026-03-31-0.052026-05-0810-Q
FY 20252025-12-31-0.322026-03-2610-K
Q3 20252025-09-30-0.302025-11-0610-Q
Q2 20262025-06-30-0.242026-08-0710-Q
Q1 20262025-03-31-0.142026-05-0810-Q
FY 20252024-12-31-0.862026-03-2610-K
Q3 20252024-09-30-0.692025-11-0610-Q
Q2 20252024-06-30-0.442025-08-0710-Q
Q1 20252024-03-31-0.272025-05-0710-Q
FY 20242023-12-31-0.862025-03-2010-K
Q3 20242023-09-30-0.592024-11-1310-Q
Q2 20242023-06-30-0.372024-08-0810-Q
Q1 20242023-03-31-0.212024-05-0710-Q
FY 20232022-12-31-0.912024-03-2610-K
Q3 20232022-09-30-0.712023-11-0210-Q
Q2 20232022-06-30-0.432023-08-0810-Q
Q1 20232022-03-31-0.172023-05-0410-Q
FY 20222021-12-31-3.132023-03-2310-K
Q3 20222021-09-30-14.872022-11-1410-Q
Q2 20222021-06-30-6.532022-08-0910-Q
Q1 20222021-03-31-1.642022-05-1110-Q
FY 20212020-12-31-23.762022-03-3010-K
Q3 20212020-09-30-18.342021-11-1710-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.